Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Hawkins DS"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 34
Tytuł:
18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.
Autorzy:
Soundararajan A
Abraham J
Nelon LD
Prajapati SI
Zarzabal LA
Michalek JE
McHardy SF
Hawkins DS
Malempati S
Keller C
Soundararajan, Anuradha
Abraham, Jinu
Nelon, Laura D
Prajapati, Suresh I
Zarzabal, Lee Ann
Michalek, Joel E
McHardy, Stanton F
Hawkins, Douglas S
Malempati, Suman
Keller, Charles
Pokaż więcej
Źródło:
Pediatric Blood & Cancer; Sep2012, Vol. 59 Issue 3, p485-492, 8p
Czasopismo naukowe
Szczegóły
Tytuł:
The clinical, research, and social value of autopsy after any cancer death: a perspective from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Autorzy:
Spunt SL
Vargas SO
Coffin CM
Skapek SX
Parham DM
Darling J
Hawkins DS
Keller C
Spunt, Sheri L
Vargas, Sara O
Coffin, Cheryl M
Skapek, Stephen X
Parham, David M
Darling, Joan
Hawkins, Douglas S
Keller, Charles
Pokaż więcej
Źródło:
Cancer (0008543X); Jun2012, Vol. 118 Issue 12, p3002-3009, 8p
Czasopismo naukowe
Szczegóły
Tytuł:
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Autorzy:
Gupta AA
Anderson JR
Pappo AS
Spunt SL
Dasgupta R
Indelicato DJ
Hawkins DS
Gupta, Abha A
Anderson, James R
Pappo, Alberto S
Spunt, Sheri L
Dasgupta, Roshni
Indelicato, Daniel J
Hawkins, Douglas S
Pokaż więcej
Źródło:
Cancer (0008543X); Feb2012, Vol. 118 Issue 4, p1130-1137, 8p
Czasopismo naukowe
Szczegóły
Tytuł:
Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy.
Autorzy:
Singh P; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Zhou L; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
Shah DA; Department of Pharmacology, Northwestern University, Chicago, IL, USA.
Cejas RB; Department of Pharmacology, Northwestern University, Chicago, IL, USA.
Crossman DK; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
Jouni M; Department of Pharmacology, Northwestern University, Chicago, IL, USA.
Magdy T; Department of Pharmacology, Northwestern University, Chicago, IL, USA.; Department of Pathology and Translational Pathobiology and Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
Wang X; Department of Biostatistics, Florida International University, Miami, FL, USA.
Sharafeldin N; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
Hageman L; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.
McKenna DE; Department of Pharmacology, Northwestern University, Chicago, IL, USA.
Horvath S; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Armenian SH; Department of Population Sciences, City of Hope, Duarte, CA, USA.
Balis FM; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Hawkins DS; Seattle Children's Hospital, Seattle, WA, USA.
Keller FG; Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
Hudson MM; St. Jude Children's Research Hospital, Memphis, TN, USA.
Neglia JP; University of Minnesota, Minneapolis, MN, USA.
Ritchey AK; Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.
Ginsberg JP; Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Landier W; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA.; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Burridge PW; Department of Pharmacology, Northwestern University, Chicago, IL, USA.
Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA. .; Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 04; Vol. 13 (1), pp. 12683. Date of Electronic Publication: 2023 Aug 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Induced Pluripotent Stem Cells*
Cardiomyopathies*/chemically induced
Cardiomyopathies*/genetics
Adult ; Humans ; Anthracyclines/adverse effects ; Case-Control Studies ; Genome-Wide Association Study ; DNA Methylation ; Epigenesis, Genetic ; DNA ; CpG Islands ; Antibiotics, Antineoplastic ; Carrier Proteins/genetics ; Membrane Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.
Autorzy:
Pacenta HL; Cook Children's Medical Center, Division of Hematology and Oncology, Fort Worth, TX 76014, USA.; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Allen-Rhoades W; Division of Pediatric Oncology, Mayo Clinic, Rochester, MN 55902, USA.
Langenau D; Molecular Pathology Unit, Massachusetts General Hospital Research Institute, Charlestown, MA 02114, USA.
Houghton PJ; Department of Molecular Medicine, Greehey Children's Cancer Research Institute, San Antonio, TX 78229, USA.
Keller C; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
Heske CM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Deel MD; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
Linardic CM; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.
Shern JF; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Stewart E; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Turpin B; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Harrison DJ; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Mascarenhas L; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA 90027, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Skapek SX; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Meyer WH; Department of Pediatrics, Jimmy Everest Section of Pediatric Hematology/Oncology, University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA.
Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA 98105, USA.
Chen EY; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
Amatruda JF; Cancer and Blood Disease Institute, Children's Hospital of Los Angeles, Los Angeles, CA 90027, USA.; Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Hingorani P; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Laetsch TW; Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Apr 01; Vol. 10 (7). Date of Electronic Publication: 2021 Apr 01.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Metabolic response as assessed by F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Autorzy:
Harrison DJ; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chi YY; University of Florida, Gainesville, FL, USA.
Tian J; University of Florida, Gainesville, FL, USA.
Hingorani P; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mascarenhas L; Children's Hospital Los Angeles and University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
McCowage GB; The Children's Hospital at Westmead, Weastmead, NSW, Australia.
Weigel BJ; University of Minnesota/Masonic Cancer Center, Minneapolis, MN, USA.
Venkatramani R; Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA.
Wolden SL; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yock TI; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Rodeberg DA; East Carolina University, Greenville, NC, USA.
Hayes-Jordan AA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Teot LA; Boston Children's Hospital, Boston, MA, USA.
Spunt SL; Lucile Packard Children's Hospital Stanford University, Palo Alto, CA, USA.
Meyer WH; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Hawkins DS; Seattle Children's Hospital, Seattle, WA, USA.
Shulkin BL; Saint Jude Children's Research Hospital, Memphis, TN, USA.
Parisi MT; Seattle Children's Hospital, Seattle, WA, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Feb; Vol. 10 (3), pp. 857-866. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*metabolism
Fluorodeoxyglucose F18/*metabolism
Positron Emission Tomography Computed Tomography/*methods
Rhabdomyosarcoma/*metabolism
Rhabdomyosarcoma/*mortality
Child ; Child, Preschool ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Infant ; Infant, Newborn ; Male ; Prognosis ; Radiopharmaceuticals/metabolism ; Rhabdomyosarcoma/pathology ; Rhabdomyosarcoma/therapy ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 34

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies